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Robust methods are needed to efficiently conduct large, multisite, randomized,
controlled clinical trials of acupuncture protocols. The Southwest Oncology Group
(SWOG) S1200 trial is a randomized, controlled (i.e., sham-controlled and waitlist-
controlled) trial of a standardized acupuncture protocol for treating aromatase inhibitor
(AI)-associated arthralgias in early-stage breast cancer patients (n Z 228). The primary
objective of this study was to determine whether true acupuncture administered twice
weekly for 6 weeks, as compared to sham acupuncture or a waitlist control, reduced
AI-associated joint pain at 6 weeks as assessed by patient reports. The study was conduct-
ed at 11 institutions across the United States. The true acupuncture protocol was devel-
oped using a consensus-based process. The true acupuncture and the sham acupunctureool of Public Health, Columbia University Medical Center, 722 West 168th Street, 7th Floor, New York,
Greenlee).
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acopuncture Institute.
Methods to Standardize Multicenter Acupuncture Trial Protocol 153protocols each consisted of 12 sessions administered for 6 weeks, followed by one weekly
session for 6 weeks. The true acupuncture protocol used standardized protocol points,
and the standardized acupoints were tailored to a patient’s joint symptoms. The similarly
standardized sham acupuncture protocol utilized superficial needling of nonacupoints.
Standardized methods were developed to train and monitor acupuncturists and included
online and in-person training, study manuals, monthly phone calls, and remote quality
assurance monitoring throughout the study period. The research staff similarly received
online and in-person training and monthly phone calls.1. Introduction
To date, there have been a limited number of multisite,
large-scale randomized controlled trials of standardized
acupuncture protocols. In this manuscript, we describe the
methods used to develop and maintain quality assurance of
an acupuncture and sham acupuncture protocol in a
multisite, large-scale randomized sham- and waitlist-
controlled trial that tested the effects of a standardized
acupuncture protocol on reducing joint pain associated
with aromatase inhibitor (AI) use among early-stage breast
cancer patients. Aromatase inhibitors are widely prescribed
to postmenopausal women for the treatment of hormone-
sensitive breast cancer; they are effective and improve
disease-free survival [1e6]. However, many women develop
joint pain and arthralgias after AI initiation and discontinue
AI treatment because of its adverse effects. No treatments
have been identified that successfully prevent or treat AI-
associated arthralgias.
The results of two previous small trials conducted by our
group suggest that acupuncture may be beneficial in
treating AI-associated arthralgias. The first study was a
waitlist-controlled trial (nZ 21) of postmenopausal women
with AI-associated arthralgias who underwent a 6-week
course of full body and auricular acupuncture [7]. Im-
provements were reported in pain severity, pain-related
functional outcomes, and physical well-being with no sig-
nificant adverse events reported. However, the study was
limited because of the small sample size and lack of a
blinded control group. The second study was a randomized,
blinded, sham-controlled trial of postmenopausal women
(nZ 38) with AI-associated arthralgias who underwent a 6-
week course of full body and auricular acupuncture [8]. The
sham acupuncture arm utilized superficial needling at
nonacupuncture points. The investigators and patients
were blinded, but not the acupuncturists. Compared to
patients in the sham arm, patients who received true
acupuncture reported a 50% decrease in the mean Brief
Pain InventoryeShort Form scores. Similar changes
occurred with the Western Ontario and McMaster Univer-
sities Osteoarthritis scores and the Modified-Score for the
Assessment and Quantification of Chronic Rheumatoid Af-
fections of the Hands (M-SACRAH) scores. These previous
results suggest that acupuncture is an effective and well-
tolerated strategy for managing AI-associated arthralgias.
However, both previous studies involved a single acupunc-
turist at a single institution. A large-scale multisite trial is
needed to test the effects of a protocol on reducing AI-
associated arthralgias among a more diverse population ofpatients in a variety of clinical and institutional settings and
implemented by multiple acupuncturists with differences in
acupuncture training.
Previous multisite acupuncture trials have used stan-
dardized protocols and have trained multiple acupunctur-
ists to implement the protocol. These studies have included
up to 638 patients who were treated at up to 37 institutions
[9e15], and the investigator teams trained acupuncturists
in person (Karen Sherman and Claudia Witt, personal
communication). To our knowledge, previous studies have
not developed methods to train and monitor acupuncturists
remotely. New robust methods to train acupuncturists to
implement clinical trial protocols are needed to efficiently
conduct large-scale acupuncture trials.2. Materials
2.1. Trial design overview
The Southwest Oncology Group (SWOG) S1200 study-
dofficially named, Randomized Blinded Sham- and
Waitlist-Controlled Trial of Acupuncture for Joint Symptoms
Related to Aromatase Inhibitors in Women with Early Stage
Breast Cancerdis funded by the following centers of the
United States (US) National Institutes of Health (NIH): Na-
tional Center for Complementary and Integrative Health
(NCCIH), National Cancer Institute (NCI), and Office of
Research on Women’s Health (R01 AT006376). The study is
being conducted within the SWOG NCI Community Oncology
Research Program (NCORP) Research Base (1UG1CA189974-
01) (www.swog.org/Visitors/AboutUs.asp). The SWOG
network includes > 4000 researchers at > 650 institutions,
which include 24 NCI-designated cancer centers and addi-
tional international cancer centers. The S1200 study is a
limited institution trial that is open at 11 institutions, which
constitute 28 clinical sites within the SWOG network.
The S1200 study is a 52-week, three-arm trial using a
2:1:1 ratio for true acupuncture, sham acupuncture, and
waitlist control, respectively (Fig. 1). Patient randomiza-
tion is dynamically balanced by the study site to account
for potential outcome differences related to discrete
acupuncture administration approaches. Two hundred and
twenty-eight patients are expected to be recruited.
Patients in the true acupuncture arm receive true
acupuncture twice weekly for 6 weeks (i.e., 12 sessions)
followed by weekly true acupuncture for 6 weeks (i.e., 6
sessions). Patients in the sham acupuncture arm receive
sham acupuncture twice weekly for 6 weeks (i.e., 12
Figure 1 The study schema.
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(i.e., 6 sessions). Patients in the waitlist control arm remain
in the waitlist condition for the full 12 weeks. As an
incentive for trial participation and to increase patients’
willingness to be randomized to the sham or waitlist control
condition, all patients receive vouchers at 24 weeks for 10
true acupuncture “bonus” sessions to be used by the 52
week study visit. Data are collected at baseline, 2 weeks, 4
weeks, 6 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks,
and 52 weeks (the outcome measures are described below).
Patients, study staff, and study clinicians are blinded to the
randomization condition (i.e., true or sham condition) of
the patients; only the study acupuncturists, the SWOG
central statistical center, and one lead site study coordi-
nator (at Columbia University, New York, NY, USA) are
aware of the randomization assignment.
2.2. Study objectives
The primary objective of the S1200 trial is to determine
whether true acupuncture administered twice weekly for 6
weeks in comparison to sham acupuncture and waitlist
control significantly reduces AI-related joint pain in women
with early-stage breast cancer, as measured by the Brief
Pain Inventory-Short Form worst pain score at 6 weeks. A
secondary objective of the S1200 study is to investigate in
this study population the effects of true acupuncture
administered twice weekly for 6 weeks followed by 6
weekly maintenance treatments, compared to the effects
of sham acupuncture and waitlist control. Additional sec-
ondary objectives will evaluate the effects of acupuncture
on self-reported pain, joint stiffness, quality of life, func-
tional testing, AI treatment adherence, pain medication
use throughout the 52-week study period, serum hormones
and inflammatory markers, and the safety of acupuncture
in this population.
2.3. Eligibility criteria, recruitment, and consent
Eligibility criteria were selected to identify postmenopausal
women with a history of early-stage hormone receptor-
positive breast cancer who developed or had worsening
joint pain and/or stiffness after initiating AI therapy. Inel-
igibility criteria included women who had underlying joint
disease or trauma, who used analgesic medication, or whohad recent exposure to acupuncture that could confound
study results. At each clinical site, the clinical and research
staff identified and recruited the trial participants. All
participants provided written consent. Institutional Review
Board approval was obtained by all participating in-
stitutions before trial initiation.
3. Procedure
3.1. Acupuncture protocols: True acupuncture and
sham acupuncture
3.1.1. Acupuncture protocol development
The acupuncture study interventions were developed by a
consensus of acupuncture experts and were based on our
previous studies of acupuncture for AI-related arthralgias
with adherence to the Standards for Reporting of
Controlled Trials in Acupuncture (STRICTA) recommenda-
tions [16]. The consensus process involved surveying 12
acupuncturists who had treated oncology patients for at
least 5 years. The acupuncturists completed a question-
naire on a variety of treatment principles and acupuncture
point protocols, which included open-ended questions on
their practice style. The true acupuncture point protocol
was then derived by consensus with respect to Traditional
Chinese Medicine differential diagnosis, treatment princi-
ples, and point prescriptions.
3.1.2. True acupuncture protocol
The true and sham acupuncture treatments consist of 12
sessions lasting 30e45 minutes each that are administered
for 6 weeks (i.e., 2 sessions per week) followed by one
session per week for the remaining 6 weeks. True
acupuncture treatment is semi-standardized. Table 1 dis-
plays the true acupuncture point protocol. The point pre-
scription is based on a standard Traditional Chinese
Medicine point prescription to treat Bi Syndrome and the
National Acupuncture Detoxification Association (NADA)
protocol applied to one ear to relieve pain and decrease
stress. At every true acupuncture visit, the patients
assigned to true acupuncture receive the full body
acupuncture prescription and the auricular acupuncture-
NADA protocol in one ear (to be alternated at each visit).
The needles remain in situ for 20e25 minutes. During this
time, the study acupuncturist returns to stimulate the
Table 1 True acupuncture protocol.
Full body acupuncture points
 SJ 5
 LI 4
 GB 41
 GB 34
 ST 41
 KD 3
Auricular acupuncture points
 Shen Men
 Kidney
 Liver
 Upper Lung
 Sympathetic
Joint-specific acupuncture point protocols
Shoulder
 LI 15
 SJ 14
 SI 10
Wrist
 SI 5
 SJ 4
 LI5
Fingers
 SI 3
 Ba Xie
 LI 3
Lumbar
 DU 3
 DU 8
 UB23
Hip
 GB 30
 GB 39
Knee
 SP 9
 SP 10
 St 34
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elicit the de qi sensation. In addition, each session includes
a joint-specific point prescription tailored for up to four of
the patient’s most painful joints such as the knees, fingers,
lumbar area, shoulders, hips, and wrists. If necessary to
access joint-specific points that are inaccessible in the su-
pine position, needles may be inserted after the first set at
the proper depth and angle to elicit the de qi sensation.
The needles are retained for 10 minutes. No electrical
stimulation is used. The anatomic site selection may vary
between visits, depending on the patient’s symptoms.
Stainless steel, single-use, sterile disposable needles are
used for the intervention and are inserted at traditional
depths and angles. Clinicians are instructed to achieve the
de qi sensation in which patients experience a dull or achy
feeling; this sensation is indicative of effective needling
[17]. Needles are re-stimulated manually once during each
session. The full body acupuncture needles used are 1 inch,
1.5 inch and 34-gauge, or 3 inches and 30-gauge (manu-
factured by Tianjin HaingLimSouWon Medical InstrumentCo., Ltd, Beijing, China and distributed by Mac Co., Roslyn
Heights, NY, USA). The auricular needles are 15 mm and 38
gauge (SEIRIN-America, Inc., Weymouth, MA, USA).
3.1.3. Sham acupuncture protocol
The number, duration, and frequency of the sessions in the
sham acupuncture group are the same as for the true
acupuncture group. Table 2 displays the sham acupuncture
point protocol. The sham acupuncture point prescription is
based on a previous cooperative group study that tested
acupuncture versus sham acupuncture for delayed nausea
in pediatric patients undergoing highly emetogenic mixed-
chemotherapy for solid tumors (Kara Kelly, personal
communication; data not published) and based on our
previous trials that utilized this sham protocol for the
indication of AI-induced arthralgias [8]. The sham protocol
consists of a core standardized prescription of minimally
invasive, shallow needle insertion utilizing thin and short
needles at nonacupuncture points. Joint-specific sham
point protocols are also based on the aforementioned
criteria and are within the proximity of the specified
anatomic area. Preliminary results from our previous
studies suggest that there is a difference between deep and
localized needling for joint pain commonly experienced by
patients with AI-induced arthralgias. Furthermore, we have
demonstrated that our sham method does provide
adequate blinding among patients [8].
In each session, four standardized points are needled
bilaterally and superficially using fine needles (i.e., super-
ficial acupuncture at nonmeridian points). De qi and
manual stimulation of the needles were avoided. The sham
acupuncture protocol also includes joint-specific treat-
ments and an auricular sham intervention that is based on
applying adhesives to nonacupuncture points on the ear.
Sham acupuncture needles are Mac single-use, sterile
disposable needles with a plastic guide tube. The sham
acupuncture needles are 0.5 inch 34-gauge needles (Tian
Jinhaing Lin Sou Won Medical Instrument Co., Ltd.). The
auricular sham product is the Sakamura Magrain Ear Pellet,
silver, with pellets removed (Sakamura Lab and Co., Kyoto,
Japan). The auricular adhesives are loosely attached and
pressed to the sham points on the helix of the auricle, and
then removed at the end of the treatment.
3.2. Training acupuncturists and clinical research
associates3.2.1. Prior training of acupuncturists
True and sham acupuncture interventions are provided by
licensed acupuncturists and medical doctor acupuncturists
licensed with the appropriate state-specific certifications
for the site. At the time of study initiation, the acupunc-
turists were already on staff at the clinical sites or were on
staff at community-based clinics affiliated with the cancer
center or academic medical center.
3.2.2. Human patient training
All acupuncturists completed human patient training per
their institutional guidelines for conducting human
research.
Table 2 Sham acupuncture protocol.
Full body acupuncture points
 Sham 1: On the lateral side of the left forearm near the elbow, 3 cun below the olecranon & 0.5 cun toward the anterior of
the small intestine acupuncture meridian.
 Sham 2: On the lateral side of the right forearm near the elbow, 3 cun below the olecranon & 0.5 cun toward the anterior
of the small intestine acupuncture meridian.
 Sham 3: At the lower border of the medial condyle of the left tibia, 1 cun anterior & superior to xi guan (Liv 7) of the liver
acupuncture meridian.
 Sham 4: At the lower border of the medial condyle of the right tibia, 1 cun anterior & superior to xi guan (Liv 7) point of
the liver acupuncture meridian.
Auricular acupuncture points
 A Sham 1: On the helix of the auricle between the ear apex & helix point #1.
 A Sham 2: On the helix of the auricle between helix point #4 & point #3.
 A Sham 3: On the helix of the auricle between helix point #5 & point #6.
Joint-specific acupuncture point protocols
 Shoulder: On the lateral side of the left or right upper arm, 5 cun below the anterior axillary fold & 1 cun anterior to the
Lung acupuncture meridian.
 Fingers/Wrist: On the lateral side of the left & right forearm near the elbow, 5 cun below the olecranon & 0.5 cun toward
the anterior of the small intestine acupuncture meridian.
 Lumbar: On the back at the level of thoracic vertebra 8, 5 cun from the center of the spine & 2 cun from the outer channel
of the urinary bladder acupuncture meridian; needled bilaterally.
 Hip: On the thigh, approximately 4 cun above the patella & 1 cun away from the anterior of the gallbladder acupuncture
meridian.
 Knee: 2 cun above sham 3 or sham 4.
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Adobe Captivate 5 software (Adobe, San Jose, CA, USA;
www.adobe.com) was used to develop online training pre-
sentations for study acupuncturists. It combines visual,
verbal, and video elements. These elements include an
introductory module, which covers general information
about the study, and two acupuncture-specific modules. An
“Introduction to the S1200 study” site training module (10
minutes) includes information on the purpose of the study,
information on SWOG study operations locations such as the
statistical center and biorepository, the S1200 study sites,
the study design and objectives, the basic eligibility
criteria, blinding, assessments, patient confidentiality,
basic adverse event reporting, and contact information.
Two modules specifically train study acupuncturists. The
first acupuncture module (15 minutes) covers data transfer
and reporting methods, notification of patient registration
and group assignment, documentation of patient visits,
treatment frequency and timing, blinding, demeanor with
studypatients, clean needle technique, and trueacupuncture
points, materials, and techniques such as pictures and verbal
descriptions of the anatomical locations of true body and
auricular points used in the study. The second acupuncture
module (10 minutes) covers sham acupuncture points, mate-
rials, and techniques (e.g., pictures and verbal descriptions of
theanatomical locationsof the shambodyandauricularpoints
used), and videos of the location and needling of each sham
body point and methods for sham auricular points.
Each module ended with a short quiz covering informa-
tion presented in themodule. Upon successful completion of
the quiz, the acupuncturist sends an electronic mail (i.e., e-
mail) message generated by the Captivate 5 program to the
coordinating clinical research associate (CRA) at Columbia
University.3.2.4. Training manuals
Written training manuals for acupuncturists were devel-
oped and distributed to each site. They cover the same
information as in the online training. The manuals are
updated throughout the duration of the trial, as needed.
3.2.5. In-person acupuncturist training
At least one acupuncturist from the initial study institutions
attended a 4-hour training session at the SWOG conference
in San Francisco, CA, USA in April 2012. The session
included a study overview presentation for S1200 acu-
puncturists, CRAs, and other S1200 staff and investigators
in attendance. A CRA-specific presentation included a
question-and-answer period. During the last 21/2 hours of
the training, the study acupuncturists were shown and
practiced sham point locations, and needling methods and
techniques. Acupuncturists (J.C., A.J.) from the lead site
(i.e., Columbia University) also conducted visits to study
sites for additional training, as needed. On-site visits last
4e6 hours, depending on the number of acupuncturists at
each site. This visit consists of reviewing the training
manual, paperwork, and procedures, and providing
approximately 11/2 hours of one-on-one training in sham
and true treatments for each acupuncturist. Ongoing
monthly teleconferences with study acupuncturists, CRAs,
and investigators are also conducted to address questions
and concerns of the study personnel.
3.2.6. Quality assurance for acupuncturists
To maintain quality assurance for the acupuncturists per-
forming the study procedure for the entire study period,
methods were devised for yearly quality assurance training
of the study acupuncturists. Quality assurance training in-
cludes two separate annual assessments. The first
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tions that are related to the study protocol and procedures.
The quiz is administered, data are collected, and answers
are discussed in an open fashion during the subsequent
monthly follow-up teleconference. The quiz answers are
also distributed to all study acupuncturists for their refer-
ence. The second training assessment is an actual practical
demonstration of study procedures with regard to greeting
and assessing the study patient, and the acupoint location
and needling technique for the true and sham protocols,
respectively. The study acupuncturists had the option of
performing a live video-based quality assurance session
with the lead site’s acupuncturist, or performing a recorded
video assessment that is sent to the lead site’s acupunc-
turist. An assessment tool using a three-point scoring sys-
tem (1 Z “pass”; 2 Z “acceptable, but needs follow up”;
and 3 Z “unacceptable and needs follow up”) is used to
assess domains such as greeting, point location accuracy,
needle technique, and any other pertinent issues in the
protocol and procedures. Table 3 displays the domains
assessed by the assessment tool. Acupuncturists scoring a 2
or 3 in any domain are provided additional written, verbal,
or video-based trainings with the lead acupuncturist, as
needed.
3.3. Randomization and blinding of acupuncture
status
Once a patient is enrolled in the trial, they are randomized
by the SWOG statistical coordinating center in a 2:1:1 ratio
for true acupuncture, sham acupuncture, and waitlist
control, respectively. If a patient is randomized to the trueTable 3 Annual live or video quality assessment domains.
Greeting
 Neutral demeanor
 Greeting for standard first visit
 Greeting for standard follow-up visit
 Inquiry about existing joint pain
Set up
 Clean field technique
 Hand washing
 Point swabbing
 Immediate isolation of used needles
Point location
 Use of bony landmarks
 Use of local anatomy
 Cun measurement
Needles
 Selection of proper needle type
 Selection of proper length
Technique
 Insertion
 Proper technique with tube
 Proper auricular technique
 Proper technique with sham needle
 Stimulation
 Obtaining de qi
 Even techniqueor sham acupuncture condition, the SWOG statistical
coordinating center sends an e-mail to the acupuncturists
to notify them that a patient has been assigned. The
acupuncturist next logs into the SWOG statistical coordi-
nating center website to retrieve the assignment. The
acupuncturist is the only member of the site study team
that is unblinded to the sham and true acupuncture
assignment.
To maintain blinding, the data on the true or sham point
prescription administered at each visit will be entered into
a separate locked database. It will only be accessible to the
study acupuncturists and an unblinded CRA at Columbia
University who does not have contact with patients.
3.4. Data collection by acupuncturists
In the S1200 trial, acupuncturists complete a SWOG case
report form for each treatment. Case report forms were
developed by the study team at Columbia University. The
forms include each participant’s ID number, initials, date,
and the acupuncturist’s name and institution. The treating
acupuncturist checks boxes to indicate the study session
number, the true or sham full body points treated, unilat-
eral point administration, and the unilateral auricular
points treated during the acupuncture session. For the true
and sham treatments groups, the additional treatment of
up to four painful joints is indicated by check boxes.
The S1200 study uses an intent-to-treat analysis. Acu-
puncturists indicate whether study patients receive fewer
acupuncture points than the full study protocol for any
reason. Acupuncturists also assist in monitoring protocol
adverse events related to the procedures by checking
whether the patient reports any bruising, bleeding, infec-
tion, needle shock, or other reactions since the previous
acupuncture session. Acupuncturists complete and submit
each treatment form within 24 hours. To submit forms,
acupuncturists scan the form to create an Adobe portable
document format (PDF) file on a secure password-protected
computer or they fax the treatment form directly to the
unblinded CRA at Columbia University. Acupuncturists log
onto a SWOG secure file transfer (sFTP) site using a SWOG ID
and password, from a preverified Internet provider address.
Once logged on to the sFTP site, the PDF file can be dragged
and dropped into a site- and patient-specific folder, which
is only accessible to the acupuncturists at their institution,
and to the unblinded CRA at Columbia University who col-
lects and records the treatment information.
3.5. Current status
The S1200 was activated on March 27, 2012. As of February
16, 2015, a total of 141 patients have been enrolled at 11
clinical sites. There are 33 acupuncturists participating in
the trial. Trial accrual is anticipated to close in October
2016.
4. Anticipated result
New robust methods were developed to train acupunctur-
ists and staff to implement a large-scale, multisite ran-
domized sham- and waitlist-controlled clinical trial to test
158 H. Greenlee et al.the effects of a standardized acupuncture protocol on AI-
associated joint pain. Novel training methods include online
training modules, peer-training, and remote quality assur-
ance monitoring. The trial is underway and trial results are
anticipated in 2017.
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